MARKET

ADIL

ADIL

Adial Pharmaceuticals Inc
NASDAQ
0.7100
-0.0051
-0.71%
After Hours: 0.7021 -0.0079 -1.11% 16:04 04/11 EDT
OPEN
0.7380
PREV CLOSE
0.7151
HIGH
0.7650
LOW
0.6970
VOLUME
41.73K
TURNOVER
--
52 WEEK HIGH
3.100
52 WEEK LOW
0.5759
MARKET CAP
4.67M
P/E (TTM)
-0.2610
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ADIL last week (0331-0404)?
Weekly Report · 4d ago
Weekly Report: what happened at ADIL last week (0324-0328)?
Weekly Report · 03/31 10:40
Weekly Report: what happened at ADIL last week (0317-0321)?
Weekly Report · 03/24 10:32
Adial Pharmaceuticals Appoints Tony Goodman as COO
TipRanks · 03/21 20:55
Weekly Report: what happened at ADIL last week (0310-0314)?
Weekly Report · 03/17 10:39
Weekly Report: what happened at ADIL last week (0303-0307)?
Weekly Report · 03/10 10:40
Adial Pharmaceuticals reports FY results
Seeking Alpha · 03/05 15:14
Based on the provided financial report, the title of the article is: "ADIAL PHARMACEUTICALS, INC. (Exact name of registrant as specified in its charter)" This is the title of the annual report filed by Adial Pharmaceuticals, Inc. with the United States Securities and Exchange Commission (SEC) for the fiscal year ended December 31, 2024.
Press release · 03/04 23:33
More
About ADIL
More
Adial Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development of therapies for the treatment and prevention of addiction and related disorders. The Company’s lead investigational new drug product, AD04, is a genetically targeted, serotonin-3 receptor antagonist, therapeutic agent for the treatment of Alcohol Use Disorder (AUD) in heavy drinking patients and was recently investigated in the Company’s ONWARD pivotal Phase III clinical trial for the potential treatment of AUD in subjects with certain target genotypes identified using the Company’s proprietary companion diagnostic genetic test. AD04 is also used for the treatment of other addictive disorders, such as Opioid Use Disorder, obesity, smoking, and other drug addictions. The Company’s wholly owned subsidiary is Purnovate, Inc.
Recently
Symbol
Price
%Change

Webull offers Adial Pharmaceuticals Inc stock information, including NASDAQ: ADIL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ADIL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ADIL stock methods without spending real money on the virtual paper trading platform.